Primary FSGS Patient Response to Immunosuppression (IS) and Risk of ESKD
John J. Sim(Kaiser Permanente), Asher D. Schachter(Visterra (United States)), Teresa N. Harrison(Kaiser Permanente), Matt Hill(Otsuka (United States)), Qiaoling Chen(Kaiser Permanente), Mercedes A. Munis(Kaiser Permanente), Min Zhuo(Visterra (United States)), Ancilla W. Fernandes(Pharmaceutical Product Development (United States)), Benjamin Lewing(Otsuka (United States))
Cited by 0
Related Papers
Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
|The Journal of Experimental Medicine|2003|897
Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible
|Nature Genetics|2006|567
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
|Journal of Clinical Investigation|2002|236
NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele
|Journal of Clinical Investigation|2002|204
On the Intraoperative Molecular Status of Renal Allografts after Vascular Reperfusion and Clinical Outcomes
|Journal of the American Society of Nephrology|2005|81